C00833-2023 |
Title of Each Class | Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding | |
---|---|---|
Common | 1,613,444,202 |
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
Subject of the Disclosure |
---|
Return of Mr. Fernando Zobel de Ayala, Independent Director, from his medical leave |
Background/Description of the Disclosure |
Please be informed that Mr. Fernando Zobel de Ayala, Independent Director of the Corporation, has returned from his medical leave. |
Name of Person | Position/Designation | Effective Date of Resignation/Cessation of term (mmm/dd/yyyy) |
Reason(s) for Resignation/Cessation | |
---|---|---|---|---|
N/A | N/A | N/A | N/A |
Name of Person | Position/Designation | Date of Appointment/Election (mmm/dd/yyyy) |
Effective Date of Appointment Election (mmm/dd/yyyy) |
Shareholdings in the Listed Company | Nature of Indirect Ownership | ||
---|---|---|---|---|---|---|---|
Direct | Indirect | ||||||
N/A | N/A | N/A | N/A | 0 | 0 | N/A |
Name of Person | Position/Designation | Date of Approval (mmm/dd/yyyy) |
Effective Date of Change (mmm/dd/yyyy) |
Shareholdings in the Listed Company | Nature of Indirect Ownership | |||
---|---|---|---|---|---|---|---|---|
From | To | Direct | Indirect | |||||
Fernando Zobel de Ayala | Member of the Corporate Governance Committee | Chairman of the Corporate Governance Committee | Feb/01/2023 | Feb/01/2023 | 1 | 0 | N/A | |
Cesar A. Buenaventura | Interim Chairman of the Corporate Governance Committee and Member of the Board Audit and Risk Oversight Committee | Member of the Corporate Governance Committee and Chairman of the Board Audit and Risk Oversight Committee | Feb/01/2023 | Feb/01/2023 | 200,001 | 0 | N/A | |
Amando M. Tetangco, Jr. | Interim Chairman of the Board Audit and Risk Oversight Committee | Member of the Board Audit and Risk Oversight Committee | Feb/01/2023 | Feb/01/2023 | 0 | 1 | Nominee Share |
Other Relevant Information |
---|
Please refer to the attached SEC Form 17-C. |
Name | Mark Hadrian Gamo |
---|---|
Designation | Legal Counsel & Corporate Secretary |